Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Nishihori
Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
1P258 Interaction Between Active State of Pharaonis Phoborhodopsin and Its Transducer Protein
Seibutsu Butsuri
Related publications
Fludarabine and Busulfan Versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS
Bone Marrow Transplantation
Transplantation
Hematology
Choosing a Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine Busulfan Versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan With Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem-Cell Transplantation in the Modern Era: A Cohort Analysis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin
Neoplasma
Cancer Research
Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphoma: A Nationwide Survey in Japan
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Multi-Institutional Study of Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Myeloablative Conditioning for Hematopoietic Stem-Cell Transplantation in Patients With Non-Malignant Diseases
Bone Marrow Transplantation
Transplantation
Hematology
Thiotepa, Busulfan and Fludarabine Compared to Busulfan and Cyclophosphamide as Conditioning Regimen for Allogeneic Stem Cell Transplant From Matched Siblings and Unrelated Donors for Acute Myeloid Leukemia
American Journal of Hematology
Hematology
